We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Updated: 8/2/2013
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Updated: 8/6/2013
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Updated: 8/6/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
IRT in Infants With Intestinal Perforation
Updated: 8/7/2013
Immunoreactive Trypsinogen in Infants With Intestinal Perforation
Status: Enrolling
Updated: 8/7/2013
IRT in Infants With Intestinal Perforation
Updated: 8/7/2013
Immunoreactive Trypsinogen in Infants With Intestinal Perforation
Status: Enrolling
Updated: 8/7/2013
Click here to add this to my saved trials
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
Updated: 8/7/2013
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
Updated: 8/7/2013
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
Click here to add this to my saved trials
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
Updated: 8/7/2013
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate and Severe Hepatic Insufficiency and Healthy Volunteers
Updated: 8/7/2013
An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers
Status: Enrolling
Updated: 8/7/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Updated: 8/13/2013
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated: 8/13/2013
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Updated: 8/13/2013
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status: Enrolling
Updated: 8/13/2013
Click here to add this to my saved trials
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Click here to add this to my saved trials
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
Updated: 8/28/2013
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
Updated: 8/28/2013
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
Updated: 8/28/2013
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
Updated: 8/28/2013
An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Open-Label Extension Study of GSK1605786A
Updated: 8/29/2013
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects With Crohn's Disease
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials